APEI vs ODD

APEI's deterministic health scores signal significant concerns: a Piotroski F-Score of 2/9 indicates weak financial health, while the absence of an Altman Z-Score raises red flags for potential distress risk. Despite strong earnings surprises and robust historical EPS growth, the stock trades at a rich forward P/E of 15.44 and a current P/E of 44.02, well above sector averages and its intrinsic value of $24.30. The company shows deteriorating revenue growth (-3.5% YoY) and negative insider sentiment with two recent sell transactions. Although profitability metrics remain positive, the combination of weak financial strength, overvaluation, and declining top-line performance suggests a high-risk profile.

ODD presents a stark contrast between deep valuation discounts and deteriorating operational health, evidenced by a weak Piotroski F-Score of 3/9. While the stock trades below its Graham Number ($16.7) and significantly below its intrinsic value ($38.52), the technical trend is overwhelmingly bearish with a 63% one-year decline. Strong revenue growth (23.5%) and high ROE (32.63%) provide a bullish fundamental foundation, but the low F-score and insider selling suggest underlying risks. The company currently functions as a high-risk value play with strong liquidity but poor momentum.